Abstract submission for the "40th General Annual Meeting of the BHS 2025" is now OPEN.
ABSTRACT GUIDELINES
- Abstract submission deadline is Sunday 1 December 2024, 23h59 CET
- Abstracts can only be submitted online via the abstract submission tol. Abstracts sent by post or email will not be accepted. No exceptions will be made.
- The content of the abstract must be related to one of the topics listed below.
- To ensure smooth scoring of papers, the topic of your work must be selected during the submission process.
- For standardization, the acceptable length of the abstract is a maximum of 500 words.
- Editing is possible by logging in with your profile until 1 December 2024, 23h59 CET
- A title which clearly indicates the nature of the investigation
- Objectives
- Methods
- Results
- Conclusion
- Figures may be included in the abstract itself
The presenting author of the abstract must be registered for the meeting.
ABSTRACT TOPICS
- Case reports
- Lymphoid malignancies and plasma cell dyscrasias
- Myeloid malignancies and cell therapies (for all diseases)
- Non-malignant hematology
Oral sessions provide an opportunity for several speakers to present their findings/papers in a formal setting as part of the meeting. Selected oral presentations consist of 6 presentations of 15 minutes. These sessions are put together by the programme committee from the top rated abstracts.
Most of the accepted abstracts are presented during the poster sessions. All the posters are displayed for consultation in the poster area of the congress. The poster presenter is requested to be present in the poster area during the presentation time.
Please note that you are not able to choose between an oral presentation and a poster presentation since the choice will be made by the programme committee and communicated on Friday 20 December 2024. The oral session and poster session guidelines will be published on the conference website in short time.